Patent Yard Sign in
Expired Canadian patentCanada

Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity

CA 1340113 C · Owner: Abou-Gharbia, Magid A. · Inventors: Abou-Gharbia, Magid A.; Childers, Wayne E. Jr.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

There are disclosed compounds of the formula (I) (see fig. I), wherein R1 is 1-adamantyl 3-methyl-1-adamantyl, 3-noradamantyl, unsubstituted or substituted-2-indolyl 3-indolyl, 2-benzofuranyl and 3-benzofuranyl wherein the substituents are selected from lower alkyl lower alkoxy, and halo; R2 is unsubstituted or substituted phenyl benzyl, pyridinyl, pyrinidinyl or pyrazinyl wherein the, substituents are selected from lower alkyl lower alkoxy, trifluoromethyl ,and halo; R3 is H or lower alkyl of 1 to 3 carbon atoms; n is the integer 0 or 1; m is the integer from 2 to 5; and the pharmaceutically acceptable salts thereof. Compounds according the present invention have demonstrated usefulness as …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted November 3, 1998. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 3, 2015.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 12, 1989
GrantedNovember 3, 1998
Term endedNovember 3, 2015
Patent numberCA 1340113 C
Classification (IPC)C07D295/15 +2 more

Timeline

Timeline From CIPO dates

199019931996199920022005200820112014Application filedMay 12, 1989Patent grantedNov 3, 1998Term endedNov 3, 2015

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.